Article
Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymerase.
Antimicrobial agents and chemotherapy - 1 Aug 2011
Berke Jan Martin, Vijgen Leen, Lachau-Durand Sophie, Powdrill Megan H, Rawe Svea, Sjuvarsson Elena, Eriksson Staffan, Götte Matthias, Fransen Els, Dehertogh Pascale, Van den Eynde Christel, Leclercq Laurent, Jonckers Tim H M, Raboisson Pierre, Nilsson Magnus, Samuelsson Bertil, Rosenquist Åsa, Fanning Gregory C, Lin Tse-I
Abstract excerpt
Chronic infection with hepatitis C virus (HCV) is a major global health burden and is associated with an increased risk of liver cirrhosis and hepatocellular carcinoma. Current therapy for HCV infection has limited efficacy, particularly against genotype 1 virus, and is hampered by a range of adverse effects. Therefore, there is a clear unmet medical need for efficacious and safe direct antiviral drugs for use in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
